Clinical trial

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant

NCT00456482 · Bausch & Lomb Incorporated, Industry · Terminated

Key facts

NCT number NCT00456482
Title Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant
Official title A Multicenter, Randomized, Double-Masked, Controlled Study to Evaluate the Safety and Efficacy of an Intravitreal Fluocinolone Acetonide Implant in Subjects With Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Lead sponsor Bausch & Lomb Incorporated, Industry
Status Terminated
Phase Phase 2/Phase 3
Study type Interventional
Conditions Non-infectious Uveitis
Intervention type Drug
Interventions Fluocinolone Acetonide 0.59mg, Fluocinolone Acetonide 2.1mg
Enrollment 239
Start date May 1, 2002
Primary completion Apr 1, 2006
Completion Apr 1, 2006
First posted Apr 5, 2007
Last update posted Dec 8, 2011

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies